EDGAR Filing Documents for 0001193125-22-066325

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-22-066325

Filing Date

2022-03-04

Accepted

2022-03-04 17:22:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 424B5	d298487d424b5.htm	424B5	310701
2	EX-FILING FEES	d298487dexfilingfees.htm	EX-FILING FEES	27580
3	GRAPHIC	g298487g15w44.jpg	GRAPHIC	41750
4	GRAPHIC	g298487g98x07.jpg	GRAPHIC	141053
	Complete submission text file	0001193125-22-066325.txt		580423

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258510 | Film No.: 22715323
SIC: 2834 Pharmaceutical Preparations